Activation of Phosphatidylinositol 3′-Kinase by Insulin-Like Growth Factor-I Rescues Promyeloid Cells from Apoptosis and Permits Their Differentiation into Granulocytes

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 829-837

  Liu, Qiang ^a   Schacher, Dan ^a   Hurth, Charlotte ^a   Freund, Gregory G ^b   Dantzer, Robert ^c   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRAIN HL 60; DRUG EFFECT; ENZYME ACTIVATION; GRANULOCYTE; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; ENZYME ACTIVATION; GRANULOCYTES; HL-60 CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION;

EID: 0031570874     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Mountz, J. D., T. Zhou, J. Wu, W. Wang, X. Su, and J. Cheng. 1995. Regulation of apoptosis on immune cells. J. Clin. Immunol. 15:1.
2. Squier, M. K. T., A. J. Sehnert, and J. J. Cohen. 1995. Apoptosis in leukocytes. J. Leukocyte Biol. 57:2.
3. Barinaga, M. 1996. Forging a path to cell death. Science 273:735.
4. L. J. Biol. Chem. 271:17601.
5. Minshall, C., S. Arkins, G. G. Freund, and K. W. Kelley. 1996. Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156:939.
6. Burgering, B. M. Th., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599.
7. Cai, Y. C., D. Cefai, H. Schneider, M. Raab, N. Nahavi, and C. E. Rudd. 1995. Selective CD28pYMNM mutations implicate phosphatidylinositol 3′-kinase in CD86-CD28-mediated costimulation. Immunity 3:417.
8. Yao, R., and G. M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003.
9. Kapeller, R., and L. C. Cantley. 1994. Phosphatidylinositol 3-kinase. Bioessays 16:565.
10. Lorenzo, M., A. M. Valverde, T. Teruel, and M. Benito. 1993. IGF-I is a mitogen involved in differentiation-related gene expression in fetal rat brown adipocytes. J. Cell Biol. 123:1567.
11. Yang, E., and S. J. Korsmeyer 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386.
12. Freund, G. G., D. T. Kulas, B. A. Way, and R. A. Mooney. 1994. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Cancer Res. 54:3179.
13. Jardieu, P., R. Clark, D. Mortensen, and K. Dorshkind. 1994. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J. Immunol. 152:4320.
14. Landreth, K. S., R. Narayanan, and K. Dorshkind. 1992. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80:1207.
15. Merchav, S., M. Lake, and A. Skottner. 1993. Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II. J. Cell Physiol. 157:178.
16. Pahlman, S., G. Meyerson, E. Lindgren, M. Schalling, and I. Johansson. 1991. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA 88:9994.
17. Rosenthal, S. M., and Z. Q. Cheng. 1995. Opposing early and late effects of insulin-like growth factor-I on differentiation and cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA 92:10307.
18. Abbasi, A. A., and D. Ridman. 1995. Effects of human growth hormone in older adults. In Human Growth Hormone Pharmacology: Basic and Clinical Aspects. K. T. Shiverick and A. L. Rosenbloom, eds. CRC Press, Boca Raton, pp 121.
19. Bennett, M. R., G. I. Evan, and S. M. Schwartz. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95:2266.
20. Lill, M. C., J. F. Fuller, R. Herzig, G. M. Crooks, and J. C. Gasson. 1995. The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation. Blood 85:692.
21. Bohnsack, J. F., and J. Chang. 1994. Activation of beta 1 integrin fibronectin receptors on HL-60 cells after granulocytic differentiation. Blood 83:543.
22. Falk, L. A., F. De-Benedetti, N. Lohrey, M. C. Birchenall-Robert, L. W. Ellingsworth, C. R. Faltynek, and F. W. Ruscetti. 1991. Induction of transforming growth factor-β protein production in retinoic acid-treated HL-60 cells: possible TGF-β-mediated autocrine inhibition. Blood 77:1248.
23. 3-induced terminal monocytic differentiation of human leukemic cell lines. J. Immunol. 150:2418.
24. 3 in induction of myeloid differentiation of human leukemic cell lines. J. Leukocyte Biol. 51:237.
25. 3 and the effect of interferon γ. J. Leukocyte Biol. 54:40.
26. Collins S. J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233.
27. Lund-Johansen, F., and L. W. M. M. Terstappen. 1993. Differential surface expression of cell adhesion molecules during granulocyte maturation. J. Leukocyte Biol. 54:47.
28. 3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J. Leukocyte Biol. 58:547.
29. Darzynkiewicz, Z., X. Li, and J. Gong. 1994. Assays of cell viability: discrimination of cells dying by apoptosis. In Flow Cytometry, Vol. 41. Z. Darzynkiewicz, J. P. Robinson, and H. A. Crissman, eds. Academic Press, San Diego, p. 16.
30. Del Bino, G., P. Lassota, and Z. Darzynkiewicz. 1991. The S-phase cytotoxicity of camptothecin. Exp. Cell Res. 172:27.
31. SAS Institute, Inc. 1989. SAS/STAT User's Guide, Version 6, Vol. 2, 4th Ed. SAS Institute, Inc., Cary, NC.
32. Thissen, J.-P., J.-M. Ketelslegers, and L. E. Underwood. 1994. Nutritional regulation of insulin-like growth factors. Endocr. Rev. 15:80.
33. Roldan, A., E. Charreau, and R. Schillaci. 1989. Insulin-like growth factor-I increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Immunol. Lett. 20:5.
34. Migliaccio, G., A. R. Migliaccio, and J. W. Adamson. 1990. The biology of hematopoietic growth factors: studies in vitro under serum-deprived conditions. Exp. Hematol. 18:1049.
35. Rabinovitch, P. S. 1994. DNA content histogram and cell cycle analysis. In Flow Cytometry, Vol. 41. Z. Darzynkiewicz, J. P. Robinson, and H. A. Crissman, eds. Academic Press, San Diego, p. 264.
36. Nissley, P., and W. Lopaczynski. 1991. Insulin-like growth factor receptors. Growth Factors 5:29.
37. Kull, F. C., S. Jacobs, Y.-F. Su, M. E. Svoboda, J. J. V. Wyk, and P. Cuatrecasas. 1982. Monoclonal antibodies to receptors for insulin and somatomedin-C. J. Biol. Chem. 258:6561.
38. Fairbairn, L. J., G. J. Cowling, B. M. Reipert, and T. M. Dexter. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823.
39. Folli, F., M. J. A. Saad, J. M. Backer, and C. R. Kahn. 1992. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J. Biol. Chem. 267:22171.
40. Kelly, K. L., and N. B. Ruderman. 1993. Insulin-stimulated phosphatidylinositol 3-kinase: association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J. Biol. Chem. 268:4391.
41. Arkins, S., N. Rebeiz, D. L. Brunke-Reese, C. Minshall, and K. W. Kelley. 1995. The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. Endocrinology 136:1153.
42. Franke, T. F., Kaplan, D. R., Cantley, L. C., Toker, A. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphophate. Science 275:665.
43. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Copper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661.
44. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544.
45. de The, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature 347:558.
46. Warrell, R. P., Jr., S. R. Frankel, W. H. Miller, Jr., D. A. Scheinberg, L. M. Itri, W. N. Hittelman, R. Vyas, M. Andreeff, A. Tafuri, A. Jakubowski, J. Gabrilove, M. S. Gordon, and E. Dmitrovsky. 1991. Differentiation therapy for acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324:1385.
47. Tsai, S., and S. J. Collins. 1993. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc. Natl. Acad. Sci. USA 90:7153.
48. Tkatch, L. S., K. A. Rubin, S. F. Ziegler, and D. J. Tweardy. 1995. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J. Leukocyte Biol. 57:964.
49. Nakajima, H., M. Kizaki, A. Sonoda, S. Mori, K. Harigaya, and Y. Ikeda. 1994. Retinoids (all-trans and 9-cis retinoic acid) stimulate production of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by human bone marrow stromal cells. Blood 84:4107.
50. Williams, G. T., C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76.
51. Weiss, M. J., and S. H. Orkin. 1995. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. USA 92:9623.
52. Weigent, D. A., and J. E. Blalock. 1995. Associations between the neuroendocrine and immune systems. J. Leukocyte Biol. 57:137.
53. Murphy, W. J., S. K. Durum, and D. L. Longo. 1992. Role of neuroendocrine hormones in murine T cell development: growth hormone exerts thymopoietic effects in vivo. J. Immunol. 149:3851.
54. Murphy, W. J., S. K. Durum, M. R. Anver, and D. L. Longo. 1992. Immunologic and hematologic effects of neuroendocrine hormones: studies on DW/J dwarf mice. J. Immunol. 148:3799.
55. Gibson, L. F., D. Piktel, and K. S. Landreth. 1993. Insulin-like growth factor-I potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82:3005.
56. Merchav, S., I. Tatarsky, and Z. Hochberg. 1988. Enhancement of human granulopoiesis in-vitro by biosynthetic insulin-like growth factor-I/somatomedin C and human growth hormone. J. Clin. Invest. 81:791.
57. McCubrey, J. A., L. S. Steelman, M. W. Mayo, P. A. Algate, R. A. Dellow, and M. Kaleko. 1991. Growth-promoting effects of insulin-like growth factor-I (IGF-I) on hematopoietic cells: overexpression of introduced IGF-I receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood 78:921.
58. Stewart, C. E. H., and P. Rotwein. 1996. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271:11330.
59. Li, Y. M., D. H. Schacher, Q. Liu, S. Arkins, N. Rebeiz, R. H. McCusker, R. Dantzer, and K. W. Kelley. 1997. Regulation of myeloid growth and differentiation by the insulin-like growth factor-I receptor. Endocrinology 138:362.